Accendra Health, Inc.
ACH
$2.04
$0.084.08%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.68% | 2.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.68% | 2.25% | |||
| Cost of Revenue | 2.84% | 4.97% | |||
| Gross Profit | 0.33% | -0.74% | |||
| SG&A Expenses | 2.77% | -0.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.37% | 1.30% | |||
| Operating Income | -63.03% | 14.48% | |||
| Income Before Tax | -119.28% | 95.72% | |||
| Income Tax Expenses | -25.35% | 274.98% | |||
| Earnings from Continuing Operations | -68.41% | 93.31% | |||
| Earnings from Discontinued Operations | 67.59% | 81.58% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 62.52% | 82.71% | |||
| EBIT | -63.03% | 14.48% | |||
| EBITDA | -57.90% | 10.89% | |||
| EPS Basic | 62.23% | 82.79% | |||
| Normalized Basic EPS | -124.35% | 555.25% | |||
| EPS Diluted | 62.00% | 82.79% | |||
| Normalized Diluted EPS | -124.35% | 555.25% | |||
| Average Basic Shares Outstanding | -0.76% | 0.46% | |||
| Average Diluted Shares Outstanding | -0.76% | 0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||